CXCL13 and melanoma: Furthermore, in vitro cytotoxicity assays revealed that the inhibitory effect of CXCL13 on melanoma cells in PBMCs could be reversed, with even 50 ng/mL CXCL13 completely reversing the PBMC‐mediated killing of melanoma cells (Figure 6F,G).